- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01732120
Off Clamp Randomization
July 19, 2022 updated by: Washington University School of Medicine
Evaluation of the Off-Clamp Robot-Assisted Partial Nephrectomy Technique in the Management of Renal Tumors
The purpose of this research study is to compare the effects on kidney function after performing the removal of a kidney tumor with or without clamping the blood vessels during surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients 18 and older.
- Patients willing and able to sign consent.
- Patients with an organ confined renal mass planning to undergo a robotic assisted partial nephrectomy (RAPN).
- Patient with Karnofsky Performance Status (KPS) equal to or greater than 40.
Exclusion Criteria:
- Patients under 18.
- Patients with Karnofsky Performance Status (KPS) less than 40.
- Patients with non-organ confined renal masses (invading renal vein, inferior vena cava, peri-renal tissue, ipsilateral adrenal gland, or metastasis).
- Patients with bilateral synchronous renal masses.
- Patients who can not discontinue Plavix, Coumadin or other anti-platelet or anti-coagulant medications.
- Patients with renal lesions determined to be too complex to perform a RAPN without clamp by the surgeon. (The renal mass may be deemed too difficult based on pre-operatively radiological findings. The surgeon's decision to exclude a mass from a robotic assisted partial nephrectomy would be based on a higher risk of positive margin or complication if a RAPN was performed.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Off-clamp partial nephrectomy
Partial nephrectomy will be performed without clamping of the renal blood vessels.
|
|
|
No Intervention: Traditional partial nephrectomy
Partial nephrectomy will be performed with clamping of the renal blood vessels.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent Change From Baseline in eGFR
Time Frame: baseline and 3 months post nephrectomy
|
Renal function following nephrectomy with and without clamping will be assessed using: percent change in eGFR from baseline to 3 months post nephrectomy.
|
baseline and 3 months post nephrectomy
|
|
Percent Change From Baseline in Split Renal Function
Time Frame: baseline to 3 months post nephrectomy
|
Renal function following nephrectomy with and without clamping will be assessed using: percent change in split renal function from baseline to 3 months post nephrectomy.
|
baseline to 3 months post nephrectomy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent of Observations With Positive Surgical Margins.
Time Frame: at the time of nephrectomy
|
Oncologic outcomes will be assessed at the time of nephrectomy based on percent of observations with positive surgical margins.
|
at the time of nephrectomy
|
|
Estimated Blood Loss
Time Frame: At the time of nephrectomy
|
Perioperative outcomes will be assessed based on estimated blood loss at the time of nephrectomy.
|
At the time of nephrectomy
|
|
Percent of Observations With Metastasis
Time Frame: 3 years
|
Oncologic outcomes will be assessed based on percent of observations with metastasis on follow-up imaging at 3 years post nephrectomy.
|
3 years
|
|
Operative Time Measured in Minutes.
Time Frame: At the time of nephrectomy
|
Perioperative outcomes will be assessed based on operative time measured in minutes at the time of nephrectomy.
|
At the time of nephrectomy
|
|
Warm Ischemia Time Measured in Minutes.
Time Frame: At the time of nephrectomy.
|
Perioperative outcomes will be assessed based on warm ischemia time measured in minutes at the time of nephrectomy.
|
At the time of nephrectomy.
|
|
Percent of Observations With Intra-operative Complications.
Time Frame: At the time of nephrectomy
|
Perioperative outcomes will be assessed based on percent of observations with intra-operative complications at the time of nephrectomy.
|
At the time of nephrectomy
|
|
Number of Hospital Days Post Nephrectomy.
Time Frame: Day of nephrectomy to day of hospital discharge.
|
Perioperative outcomes will be assessed based number of hospital days post nephrectomy.
|
Day of nephrectomy to day of hospital discharge.
|
|
Percent of Observations With Postoperative Complications.
Time Frame: Within 3 months post nephrectomy.
|
Perioperative outcomes will be assessed based on percent of observations with postoperative complications.
|
Within 3 months post nephrectomy.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Robert S Figenshau, MD, Washington University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (Actual)
May 31, 2017
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
November 16, 2012
First Submitted That Met QC Criteria
November 21, 2012
First Posted (Estimate)
November 22, 2012
Study Record Updates
Last Update Posted (Actual)
May 19, 2023
Last Update Submitted That Met QC Criteria
July 19, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- myIRB ID 201208091
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.